Autoimmune Diseases  >>  Symlin (pramlintide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT00042471: Evaluation of the Bioavailability of Pramlintide

Completed
2
75
US
Pramlintide acetate, Symlin (pramlintide acetate)
AstraZeneca
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
12/02
12/02
NCT00042601: Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Completed
2
51
RoW
Pramlintide acetate, Placebo
AstraZeneca
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
10/03
10/03
NCT00313183: A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

Completed
2
12
US
pramlintide acetate, Symlin
AstraZeneca
Type 1 Diabetes Mellitus
08/07
08/07

Download Options